| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25021-463-01 | 25021-463 | HUMAN PRESCRIPTION DRUG | Octreotide Acetate | octreotide acetate | INJECTION, SOLUTION | INTRAVENOUS; SUBCUTANEOUS | 20230615 | N/A | ANDA | ANDA090834 | Sagent Pharmaceuticals | OCTREOTIDE ACETATE | 50 ug/mL | 10 VIAL in 1 CARTON (25021-463-01) / 1 mL in 1 VIAL |
| 25021-464-01 | 25021-464 | HUMAN PRESCRIPTION DRUG | Octreotide Acetate | octreotide acetate | INJECTION, SOLUTION | INTRAVENOUS; SUBCUTANEOUS | 20230615 | N/A | ANDA | ANDA090834 | Sagent Pharmaceuticals | OCTREOTIDE ACETATE | 100 ug/mL | 10 VIAL in 1 CARTON (25021-464-01) / 1 mL in 1 VIAL |
| 25021-465-01 | 25021-465 | HUMAN PRESCRIPTION DRUG | Octreotide Acetate | octreotide acetate | INJECTION, SOLUTION | INTRAVENOUS; SUBCUTANEOUS | 20230615 | N/A | ANDA | ANDA090834 | Sagent Pharmaceuticals | OCTREOTIDE ACETATE | 500 ug/mL | 10 VIAL in 1 CARTON (25021-465-01) / 1 mL in 1 VIAL |